Literature DB >> 21847008

In vitro migration capacity of human adipose tissue-derived mesenchymal stem cells reflects their expression of receptors for chemokines and growth factors.

Sun Jin Baek1, Sung Keun Kang, Jeong Chan Ra.   

Abstract

The homing properties of adipose tissue-derived mesenchymal stem cells (AdMSCs) have stimulated intravenous applications for their use in stem cell therapy. However, the soluble factors and corresponding cellular receptors responsible for inducing chemotaxis of AdMSCs have not yet been reported. In the present study, the migration capacity of human AdMSCs (hAdMSCs) toward various cytokines or growth factors (GFs) and the expression of their receptors were determined. In a conventional migration assay, PDGF-AB, TGF-β1, and TNF-α showed the most effective chemoattractant activity. When AdMSCs were preincubated with various chemokines or GF, and then allowed to migrate toward medium containing 10% FBS, those preincubated with TNF-α showed the highest migratory activity. Next, hAdMSCs were either preincubated or not with TNF-α, and allowed to migrate in response to various GFs or chemokines. Prestimulation with TNF-α increased the migration activity of hAdMSCs compared to unstimulated hAdMSCs. When analyzed by FACS and RT-PCR methods, hAdMSCs were found to express C-C chemokine receptor type 1 (CCR1), CCR7, C-X-C chemokine receptor type 4 (CXCR4), CXCR5, CXCR6, EGF receptor, fibroblast growth factor receptor 1, TGF-β receptor 2, TNF receptor superfamily member 1A, PDGF receptor A and PDGF receptor B at both the protein and the mRNA levels. These results indicate that the migration capacity of hAdMSCs is controlled by various GFs and chemokines. Prior in vitro modulation of the homing capacity of hAdMSCs could stimulate their movement into injured sites in vivo when administered intravenously, thereby improving their therapeutic potential.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21847008      PMCID: PMC3222821          DOI: 10.3858/emm.2011.43.10.069

Source DB:  PubMed          Journal:  Exp Mol Med        ISSN: 1226-3613            Impact factor:   8.718


  24 in total

1.  Transplantation of adipose tissue-derived stromal cells increases mass and functional capacity of damaged skeletal muscle.

Authors:  Francis Bacou; Ramzi Boubaker el Andalousi; Paul-André Daussin; Jean-Paul Micallef; Jonathan M Levin; Michel Chammas; Louis Casteilla; Yves Reyne; Jean Nouguès
Journal:  Cell Transplant       Date:  2004       Impact factor: 4.064

Review 2.  Human bone marrow and adipose tissue mesenchymal stem cells: a user's guide.

Authors:  Federico Mosna; Luc Sensebé; Mauro Krampera
Journal:  Stem Cells Dev       Date:  2010-10       Impact factor: 3.272

3.  Adipogenic potential of human adipose derived stromal cells from multiple donors is heterogeneous.

Authors:  A Sen; Y R Lea-Currie; D Sujkowska; D M Franklin; W O Wilkison; Y D Halvorsen; J M Gimble
Journal:  J Cell Biochem       Date:  2001-03-26       Impact factor: 4.429

4.  Multilineage cells from human adipose tissue: implications for cell-based therapies.

Authors:  P A Zuk; M Zhu; H Mizuno; J Huang; J W Futrell; A J Katz; P Benhaim; H P Lorenz; M H Hedrick
Journal:  Tissue Eng       Date:  2001-04

5.  Intraarterial administration of marrow stromal cells in a rat model of traumatic brain injury.

Authors:  D Lu; Y Li; L Wang; J Chen; A Mahmood; M Chopp
Journal:  J Neurotrauma       Date:  2001-08       Impact factor: 5.269

6.  Multilineage potential of adult human mesenchymal stem cells.

Authors:  M F Pittenger; A M Mackay; S C Beck; R K Jaiswal; R Douglas; J D Mosca; M A Moorman; D W Simonetti; S Craig; D R Marshak
Journal:  Science       Date:  1999-04-02       Impact factor: 47.728

7.  Intracerebral transplantation of bone marrow with BDNF after MCAo in rat.

Authors:  J Chen; Y Li; M Chopp
Journal:  Neuropharmacology       Date:  2000-03-03       Impact factor: 5.250

8.  Xenotransplant cardiac chimera: immune tolerance of adult stem cells.

Authors:  Takayuki Saito; Jin-Qiang Kuang; Bindu Bittira; Abdulaziz Al-Khaldi; Ray C J Chiu
Journal:  Ann Thorac Surg       Date:  2002-07       Impact factor: 4.330

9.  BMP-2, BMP-4, and PDGF-bb stimulate chemotactic migration of primary human mesenchymal progenitor cells.

Authors:  Jörg Fiedler; Götz Röderer; Klaus-Peter Günther; Rolf E Brenner
Journal:  J Cell Biochem       Date:  2002       Impact factor: 4.429

10.  A two-way interaction between hepatocyte growth factor and interleukin-6 in tissue invasion of lung cancer cell line.

Authors:  Yasuo To; Makoto Dohi; Kunio Matsumoto; Ryoichi Tanaka; Atsushi Sato; Kazuyuki Nakagome; Toshikazu Nakamura; Kazuhiko Yamamoto
Journal:  Am J Respir Cell Mol Biol       Date:  2002-08       Impact factor: 6.914

View more
  65 in total

1.  Autologous stromal vascular fraction therapy for rheumatoid arthritis: rationale and clinical safety.

Authors:  Jorge Paz Rodriguez; Michael P Murphy; Soonjun Hong; Marialaura Madrigal; Keith L March; Boris Minev; Robert J Harman; Chien-Shing Chen; Ruben Berrocal Timmons; Annette M Marleau; Neil H Riordan
Journal:  Int Arch Med       Date:  2012-02-08

2.  Kidney injury molecule-1 is involved in the chemotactic migration of mesenchymal stem cells.

Authors:  Kyung-Mee Park; Hyun-Suk Nam; Pankaj Kumar Teotia; Kamal Hany Hussein; Seok-Ho Hong; Jung-Im Yun; Heung-Myong Woo
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-03-21       Impact factor: 2.416

Review 3.  Biological functions of mesenchymal stem cells and clinical implications.

Authors:  Abderrahim Naji; Masamitsu Eitoku; Benoit Favier; Frédéric Deschaseaux; Nathalie Rouas-Freiss; Narufumi Suganuma
Journal:  Cell Mol Life Sci       Date:  2019-05-04       Impact factor: 9.261

4.  Stem cell therapy: a potential for the perils of pancreatitis.

Authors:  Harleen Chela; Bhupinder S Romana; Markandeya Madabattula; Abdulmajeed A Albarrak; Mohamad H Yousef; Sami Samiullah; Veysel Tahan
Journal:  Turk J Gastroenterol       Date:  2020-06       Impact factor: 1.852

Review 5.  Harnessing the mesenchymal stem cell secretome for regenerative urology.

Authors:  Daniel Z Sun; Benjamin Abelson; Paurush Babbar; Margot S Damaser
Journal:  Nat Rev Urol       Date:  2019-06       Impact factor: 14.432

6.  Effect of a CCR1 receptor antagonist on systemic trafficking of MSCs and polyethylene particle-associated bone loss.

Authors:  Emmanuel Gibon; Zhenyu Yao; Allison J Rao; Stefan Zwingenberger; Barbara Batke; Roberto Valladares; Robert L Smith; Sandip Biswal; Sanjiv S Gambhir; Stuart B Goodman
Journal:  Biomaterials       Date:  2012-02-23       Impact factor: 12.479

Review 7.  In situ tissue regeneration: chemoattractants for endogenous stem cell recruitment.

Authors:  Wendy S Vanden Berg-Foels
Journal:  Tissue Eng Part B Rev       Date:  2013-07-11       Impact factor: 6.389

8.  Aging mesenchymal stem cells fail to protect because of impaired migration and antiinflammatory response.

Authors:  Martha L Bustos; Luai Huleihel; Maria G Kapetanaki; Christian L Lino-Cardenas; Lyle Mroz; Bryon M Ellis; Bryan J McVerry; Thomas J Richards; Naftali Kaminski; Nayra Cerdenes; Ana L Mora; Mauricio Rojas
Journal:  Am J Respir Crit Care Med       Date:  2014-04-01       Impact factor: 21.405

9.  CD140b (PDGFRβ) signaling in adipose-derived stem cells mediates angiogenic behavior of retinal endothelial cells.

Authors:  Ramesh Periasamy; Sally L Elshaer; Rajashekhar Gangaraju
Journal:  Regen Eng Transl Med       Date:  2018-06-29

10.  Obesity Determines the Immunophenotypic Profile and Functional Characteristics of Human Mesenchymal Stem Cells From Adipose Tissue.

Authors:  Gisela Pachón-Peña; Carolina Serena; Miriam Ejarque; Jordi Petriz; Xevi Duran; W Oliva-Olivera; Rafael Simó; Francisco J Tinahones; Sonia Fernández-Veledo; Joan Vendrell
Journal:  Stem Cells Transl Med       Date:  2016-03-08       Impact factor: 6.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.